Skip to main content
Log in

Cyclosporin in Behçet's disease: Results in 16 patients after 24 months of therapy

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Summary

The aim of this study was to evaluate the usefulness of cyclosporin in Behçet's disease. Sixteen subjects (10 males and 6 females; mean age 25.2 years) affected by the complete type of Behçet's syndrome received 5 mg/kg/day of cyclosporin for 24 months. A marked improvement of the symptoms was observed after three months of therapy. Within 6 to 12 months of treatment 14 of the 16 patients obtained a complete clinical remission. Biochemical and immunological parameters were controlled periodically to evaluate the clinical response and the possible side-effects. Two patients dropped out of the study because of anaemia and renal dysfunction, which returned to normal when cyclosporin was withdrawn. Our results confirm the efficacy of cyclosporin in the treatment of Behçet's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yazici, H., Akokan, G., Yalcin, B., Muftuogla, A. The high prevalence of HLA-B5 in Behçet's disease. Clin Exp Immunol 1977, 30, 259–261.

    PubMed  Google Scholar 

  2. Ohno, S., Aoiki, K., Suguira, S., Nakayama, E., Ikatura, K., Aizawa, M. HLA-B5 and Behçet's disease. Lancet 1973, ii, 1383–1384.

    Article  Google Scholar 

  3. Lehner, T., Welsh, K.L., Batchelor, J.R. The relationship of HLA-B and DR phenotypes to Behçet's syndrome, recurrent oral ulceration and the class of immune complexes. Immunology 1982, 47, 581–587.

    PubMed  Google Scholar 

  4. Lehner, T., Almeida, J.D., Levinsky, R.J. Damage membrane fragments and immune complex in the blood of patients with Behçet's syndrome. Clin Exp Immunol 1978, 34, 206–212.

    PubMed  Google Scholar 

  5. Levinsky, R.J., Lehner, T. Circulating soluble immune complexes in recurrent oral ulceration and Behçet's syndrome. Clin Exp Immunol 1978, 32, 193–198.

    PubMed  Google Scholar 

  6. Williams, B.D., Lehner, T. Immune complexes in Behçet's syndrome and recurrent oral ulceration. B Med J 1977, 1, 1387–1389.

    Google Scholar 

  7. Lim, S.D., Haw, C.R., Kim, N.I., Fusaro, R.M. Abnormalities of T-cell subsets in Behçet's syndrome. Arch Dermatol 1983, 119, 307–311.

    Article  PubMed  Google Scholar 

  8. O'Duffy, J.D., Robertson, D.M., Goldstein, N.P. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease. Am J Med 1984, 76, 75–84.

    Article  PubMed  Google Scholar 

  9. Tabbara, K.F. Chlorambucil in Behçet's disease, a reappraisal Ophtalmology 1983, 90, 906–908. Br J Ophthalmol 1976, 60, 55–57.

    PubMed  Google Scholar 

  10. Triculis, D. Treatment of Behçet's disease with chlorambucil. Br J Ophtamol 1976, 60, 55–57.

    Google Scholar 

  11. Oniki, S., Kurakazu, K., Kawata, K. Immunosuppressive treatment of Behçet's disease with cyclophosphamide. Jpn J Ophtalmol 1976, 20, 32–40.

    Google Scholar 

  12. Rosselet, E., Saudan, Y., Znkusen, G. Les effects de la Azathioprine dans le maladie de Behçet. Premiers resultats therapeutiques. Ophthalmologica 1968, 156, 218–222.

    PubMed  Google Scholar 

  13. Saito, K., Ohguchi, M., Sugiura, S. Colchicine treatment in Behçet's disease. Ophthalmology 1977, 19, 115–120.

    Google Scholar 

  14. BenEzra, D., Cohen, E., Chajek, T., Friedman, G., Pizanti, S., de Courten, C., Harris, W. Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome. Transplant Proc 1988, 3, 136–143.

    Google Scholar 

  15. Nussenblatt, R.B., Rodrigues, M.M., Wacker, W.B., Cevario, S.J., Salinas-Carmona, M.C. Cyclosporin A: inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest 1981, 67, 1228–1231.

    PubMed  Google Scholar 

  16. Nussenblatt, R.B., Palestine, A.G., Chi-Chao, C., Manabu, M., Yancey, K. Effectiveness of cyclosporin therapy for Behçet's disease. Arthritis Rheum 1985, 28, 671–679.

    PubMed  Google Scholar 

  17. Choen, D.J., Loertscher, R., Rubin, M.F. Cyclosporin: a new immuno-suppressive agent for organ transplantation. Ann Int Med 1984, 101, 667–682.

    PubMed  Google Scholar 

  18. Borel, J.F., Lafferty, K.J. Cyclosporin: speculation about its mechanism of action. Transplant Proc 1983, 15, 1881–1885.

    Google Scholar 

  19. Nanba, K., Masuda, K. Clinical features of severe case with Behçet's disease. Jpn J Clin Ophthalmol 1982, 36, 1241–1245.

    Google Scholar 

  20. Nussenblatt, R.B. The use of cyclosporine in ocular inflammatory disorders. Transplant Proc 1988, 81, 545–546.

    Google Scholar 

  21. Ohno, S. Immunological aspects of Behçet's, Vogt-Koyonagi and Harada's diseases. Trans Ophtalmol Soc UK 1981, 101, 335–341.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacor, M.L., Biasi, D., Lunardi, C. et al. Cyclosporin in Behçet's disease: Results in 16 patients after 24 months of therapy. Clin Rheumatol 13, 224–227 (1994). https://doi.org/10.1007/BF02249016

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02249016

Key words

Navigation